http://www.nelm.nhs.uk
- Triple combination therapy with liraglutide, metformin and rosiglitazone in patients with type 2 diabetes mellitus
http://www.nelm.nhs.uk/en/NeLM-Area/News/2009---March/18/Triple-combination-therapy-with-liraglutide-metformin-and-rosiglitazone-in-patients-with-type-2-diabetes-mellitus-/
- New drug application submitted to FDA for Afresa(tm) (inhaled insulin) for treatment of diabetes
http://www.nelm.nhs.uk/en/NeLM-Area/News/2009---March/18/New-drug-application-submitted-to-FDA-for-Afresa-inhaled-insulin-for-treatment-of-diabetes-/
- Predicting risk of type 2 diabetes in primary care: QDScore
http://www.nelm.nhs.uk/en/NeLM-Area/News/2009---March/19/Predicting-risk-of-type-2-diabetes-in-primary-care-QDScore/
No comments:
Post a Comment